VANCOUVER, BC / ACCESSWIRE / December 10, 2019 / Else Nutrition Holdings Inc. ("Else Nutrition" or the "Company") (TSXV:BABY) (OTCQB:BABYF) is pleased to announce that its common shares have been approved for trading on the OTCQB Market ("OTCQB") under the symbol "BABYF" effective as of the open of trading today, December 10, 2019.

The OTCQB is a venture market operated by OTC Markets Group and designed for early-stage and developing U.S. and international companies. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process. To learn more, visit otcmarkets.com.

About Else Nutrition Holdings Inc.

The Company is a food and nutrition company focused on research, development, manufacturing, marketing, sale and/or license of innovative plant-based food and nutrition products to the infant, toddler, children and adult markets.

For further information, please contact:

Chelsie Hodge, Director of Corporate Relations
ELSE Nutrition Holdings Inc.
E: chelsieh@elsenutrition.com
P: (604)360-2977

Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: hamutaly@elsenutrition.com
P: +972(0)52-447-9931

TSX Venture Exchange

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Else Nutrition Holdings Inc.

ReleaseID: 569706

VANCOUVER, BC / ACCESSWIRE / December 10, 2019 / Glance Technologies Inc. (CSE:GET)(OTCQB:GLNNF)(FKT:GJT) ("Glance" or the "Company") one of Canada's leading mobile payments and customer loyalty platforms, today announced the implementation of a restricted share unit (RSU) award plan (the "RSU Plan").

Subject to ratification by disinterested shareholders at the Company's next Annual General Meeting ("AGM"), the Company has initially awarded 1,126,000 RSUs to employees of the Company, of which 865,000 vest over 36 months, in equal quarterly installments and 261,000 vest subject to meeting certain conditions or performance milestones.

Pursuant to the terms of the RSU Plan, the number of RSUs issuable under the RSU Plan, together with the number of common shares issuable under options that are outstanding under the Company's Stock Option Plan, will not exceed 10% of the issued and outstanding common shares as at the date of a grant under the RSU Plan or the Stock Option Plan, as the case may be.

"This combination of salary and equity is designed to incentivize employees," said Glance's Interim CEO Jonathan Hoyles. "Allocating RSUs to Glance employees fosters an ownership mentality at the Company and is also consistent with our efforts to spend wisely, conserve cash and maintain a lean culture. We understand the importance of continually re-enforcing a cost-conscious culture, particularly in a business incurring net losses."

Hoyles has agreed to receive one-fifth of his current remuneration in the form of RSUs and the Board has also agreed to take 50 per cent of its current board compensation in the form of ongoing grants of RSUs. Similar packages have been and will continue to be offered to future employees with the goal to weight individual compensations to RSUs and stock options rather than cash.

In a similar arrangement, Paola Ashton, VP Business and Client Development, has agreed to receive one-fifth of her compensation in the form of stock of the Company.

"These plans are very common in startup environments where it takes time to get to cash flow positive and companies such as Glance look for a compensation strategy that builds a long-term and high level of commitment," explained Hoyles. "RSUs can effectively engage employees in the longer term and create a sense of ownership."

"Moreover, it lessens the up-front financial burden of paying out competitive market salaries, and it attracts employees who are committed to working harder in order to ensure their financial well-being and the success of the company."

A description of the RSU Plan and the awards made under such plan will be set out in the Management Information Circular of the Company, which will be sent to shareholders and filed on SEDAR in connection with the AGM.

About Glance Technologies

Vancouver-based Glance Technologies is the parent company of Glance Pay (https://glancepay.com), a streamlined mobile payment app and loyalty management platform that provides fast, frictionless payments and digital rewards, resulting in a better customer experience. Glance Pay has established a foothold in the full-service restaurant sector where the platform enables merchants to not only accept in-dining mobile payments, but also automate loyalty, and instantly deliver rewards to customers based on their purchasing patterns.

For more information, contact:

Jonathan Hoyles
Interim Chief Executive Officer
833-338-0299
investors@glancepay.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements (collectively "forward-looking information") within the meaning of applicable securities laws. Forward-looking information is typically identified by words such as: "may", "believe", "thinks", "expect", "exploring", "expand", "could", "anticipate", "intend", "estimate", "plan", "pursue", "potentially", "projected", "should", "will" and similar expressions, or are those, which, by their nature, refer to future events. These forward-looking statements, which involve risks and uncertainties, relate to, among other things, the discussion of Glance's business strategies and its expectations concerning future operations, that in time Glance could become cash flow positive, and that Glance's compensation strategy will build a long-term and high level of commitment from its employees. Although Glance considers these forward-looking statements to be reasonable based on information currently available to it, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. The forward-looking information in this press release is also based on certain estimates, forecasts and projections, as well as expectations, beliefs and assumptions, including, among other things, that Glance will be able to achieve its business and technology development objectives. For additional information with respect to these and other factors and assumptions underlying the forward-looking statements in this press release, see the section entitled "Risk Factors" in the most recent Annual Information Form and Prospectus of Glance, which may be accessed through Glance's profile on SEDAR at www.sedar.com. Glance cautions investors that any forward-looking information provided by Glance is not a guarantee of future results or performance, and that actual results may differ materially from those in forward-looking statements. Undue reliance should not be placed on such forward-looking information, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur.

SOURCE: Glance Technologies Inc.

ReleaseID: 569701

SAN FRANCISCO, CA / ACCESSWIRE / December 10, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), today announced that the Company's wholly-owned subsidiary, Napo Pharmaceuticals, Inc. ("Napo"), is hosting an HIV Activism Digital Summit on Friday, December 13, 2019 from 3 p.m. to 5 p.m. Eastern. The summit will feature commentary by prominent HIV advocates Bruce Richman, Maria Mejia, and Ken Williams (AKA Ken Like Barbie), as well as by Jaguar CEO Lisa Conte and Napo employee Brian Coppedge. Josh Robbins will serve as the host of the event, which will be the first completely digital, activist-led virtual program in the HIV community and is intended to continue fostering the important conversations needed to address living with HIV and living with comorbidities like HIV-associated diarrhea. To sign up for free to view the live summit, visit https://napopharma.com/summit. The discussion can be viewed on Napo's Facebook page (facebook.com/napopharma), Napo's website (https://napopharma.com/summit) and on Crowdcast (https://www.crowdcast.io/e/hivsummit).

"We are very proud that Napo's first HIV Activism Digital Summit will feature such extraordinary activists," Robbins commented. "These powerhouse advocates comprise an HIV activism dream team because of their incredible work that continues to lead to real change for people living with HIV."

Richman, who will serve as the summit's keynote speaker, is the founding executive director of the Prevention Access Campaign and the "Undetectable = Untransmittable (U=U)" campaign. He has worked in global philanthropy for over two decades developing foundations, cause-marketing and grantmaking programs, social marketing campaigns, and interventions on a range of issues including HIV stigma and prevention. Richman was honored for his work with U=U as Healthline's HIV influencers "2017 Person of the Year" and named Plus Magazine "#1 Most Amazing HIV+ People of 2018". He received his Ed.M. in Administration, Planning & Social Policy from Harvard Graduate School of Education and his J.D. from Harvard Law School.

Diagnosed with HIV in 1991, Mejia has since become a tireless advocate for people living with HIV. She is a global ambassador for The Well Project, an international nonprofit for women and girls with HIV, the founder of two international Facebook support groups, an HIV counselor, and co-author of From a Warrior's Passion and Pain, a real-life account of her battle with HIV. She has spoken at national and international conventions and been featured in numerous campaigns including the Greater Than AIDS campaign on IPV, HIV and women, the Centers for Disease Control's campaign, "Let's Stop HIV Together", The Stigma Project and the Office of Women's Health's National Women and Girls HIV/AIDS Awareness Day.

Williams, an activist and advocate living with HIV, is the creative force behind the award-winning video blog Ken Like Barbie. He has collaborated on projects with the Black AIDS Institute, the Centers for Disease Control and Prevention, Greater Than AIDS, and HIV.gov (where he's a regular blogger for the Black Voices project).

Coppedge, a specialty territory manager at Napo, has spent twenty years working to meet the health needs of people living with HIV/AIDS. Prior to joining Napo, he spent 11 years with Bristol-Myers Squibb, serving in roles involving both patient and community affairs management and sales. Coppedge is also an experienced health educator and the former executive director of a Seattle-based HIV/AIDS non-profit.

Robbins is an HIV activist, blogger, writer, social media marketer, and a consultant to Napo. He was recently honored with the National Lesbian & Gay Journalist Association "Excellence in Journalism: Blogging Award". He is a GLAAD-nominated blogger, a keynote and university speaker on sexual health and overcoming difficulty to live well, and he gave a TEDx Talk on how patients use social media to maintain healthy lifestyles despite chronic conditions.

About Jaguar Health, Inc.

Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

For more information about Jaguar, please visit jaguar.health. For more information about Napo, visit napopharma.com.

About Mytesi®

Mytesi (crofelemer) is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART). Mytesi is not indicated for the treatment of infectious diarrhea. Rule out infectious etiologies of diarrhea before starting Mytesi. If infectious etiologies are not considered, there is a risk that patients with infectious etiologies will not receive the appropriate therapy and their disease may worsen. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (5.7%), bronchitis (3.9%), cough (3.5%), flatulence (3.1%), and increased bilirubin (3.1%).

See full Prescribing Information at Mytesi.com. Crofelemer, the active ingredient in Mytesi, is a botanical (plant-based) drug extracted and purified from the red bark sap of the medicinal Croton lechleri tree in the Amazon rainforest. Napo has established a sustainable harvesting program for crofelemer to ensure a high degree of quality and ecological integrity.

Forward-Looking Statements

Certain statements in this press release constitute "forward-looking statements." These include statements regarding the expectation that Napo will host an HIV Activism Digital Summit December 13, 2019. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Some of the factors that could affect our actual results are included in the periodic reports on Form 10-K and Form 10-Q that we file with the Securities and Exchange Commission. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contact:

Peter Hodge
Jaguar Health, Inc.
phodge@jaguar.health
Jaguar-JAGX

SOURCE: Jaguar Health, Inc.

ReleaseID: 569694

INCLINE VILLAGE, NV / ACCESSWIRE / December 10, 2019 / American Battery Metals Corporation (OTCQB:ABML) (the "Company"), a premier battery metal exploration and development and battery recycling company based in Nevada, today commented on the planned joint venture between General Motors and LG Chem.

The American auto manufacturer and South Korean chemical and battery manufacturing company will invest $2.3 billion USD to build an electric vehicle battery cell plant in Ohio, creating one of the world's largest battery manufacturing facilities. The plant is projected to have a 30 gigawatt capacity.

"This is a significant announcement between two global companies," said American Battery Metals Corporation CEO Doug Cole. He continued, "When two giants like GM and LG invest this kind of money to create a battery manufacturing plant, it's a clear indicator that the explosive projections for the adoption of EV are accurate. And it is particularly noteworthy that they will build this factory in the United States."

American Battery Metals Corporation head of business development and government affairs, Doug Nickle, said "This announcement will not go unnoticed by investors in the lithium and battery metals markets. Depressed lithium prices, due to the "oversupply myth," will likely see a turnaround in 2020 as the world realizes that the massive demand projections for EV are real and will require much more EV battery grade lithium than is currently available."

As the EV and energy storage markets continue to experience seismic growth, new sources of battery metals need to be developed. American Battery Metals Corporation is uniquely positioned to address the existing supply chain shortages through the company's exploration and mining and battery recycling divisions. "We are aggressively working to develop both our primary sources of battery materials through environmentally-sustainable mining, and we are "re-mining" lithium ion batteries through our next-gen recycling process," said CEO Doug Cole.

ABMC will discuss the economic and national security implications of the electric revolution as it meets with American lawmakers and personnel from multiple government agencies this week in Washington, D.C.

American Battery Metals Corporation

American Battery Metals Corporation (www.batterymetals.com) (OTCQB:ABML) is a premier battery metal exploration and development company based in Nevada. The company is focused on its Railroad Valley battery metal project in Nevada with the goal of becoming a substantial domestic supplier of battery metals to the increasing electric vehicles and battery storage markets in America.

For more information, please visit:www.batterymetals.com

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the expected project economics for Western Nevada Basin (Railroad Valley), including estimates of life of mine, average production, cash costs, AISC, initial CAPEX, sustaining CAPEX, pre-tax IRR, pre-tax NPV, net cash flows and recovery rates, the impact of self-mining versus contract mining, the timing to obtain necessary permits, the submission of the project for final investment approval and the timing of initial gold production after investment approval and full financing, metallurgy and processing expectations, the mineral resource estimate, expectations regarding the ability to expand the mineral resource through future drilling, ongoing work to be conducted at the Western Nevada Basin (Railroad Valley), and the potential results of such efforts, the potential commissioning of a Pre-Feasibility study and the effects on timing of the project, are "forward-looking statements." Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve a number of risks and uncertainties, which could cause the Company's future results to differ materially from those anticipated. Potential risks and uncertainties include, among others, interpretations or reinterpretations of geologic information, unfavorable exploration results, inability to obtain permits required for future exploration, development or production, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; fluctuating mineral and commodity prices, final investment approval and the ability to obtain necessary financing on acceptable terms or at all. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended September 30, 2018. The Company assumes no obligation to update any of the information contained or referenced in this press release.

Contact Information

p775-473-4744
info@batterymetals.com

SOURCE: American Battery Metals Corporation

ReleaseID: 569569

Viveve 2.0 System and consumable treatment tips now commercially available in U.S., European Union, China, and Korea

ENGLEWOOD, CO / ACCESSWIRE / December 10, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced registration clearance by the Korean Ministry of Food and Drug Safety for the company's next generation Viveve 2.0 cryogen-cooled monopolar radiofrequency (CMRF) system for use in general surgical procedures for electrocoagulation and hemostasis as well as for the treatment of vaginal laxity.

"We are pleased to have received our most recent clearance of the Viveve 2.0 System and its consumable treatment tips in South Korea, one of the largest and most influential global markets for women's aesthetic and intimate health procedures. JOYMG Co., Ltd., Viveve's exclusive distribution partner in South Korea, serves an established and growing base of physician customers who demand the latest advances in medical technology. We look forward to continuing our support of JOYMG in their efforts to expand awareness and adoption of Viveve's 2.0 System as a clinically proven safe and effective treatment to improve vaginal laxity," said Scott Durbin, Viveve's chief executive officer and director.

Clearance of the Viveve 2.0 System in South Korea represents the latest milestone in Viveve's ongoing regulatory strategy to expand the global commercial footprint of its next generation CMRF technology platform. The 2.0 System and consumable treatment tips are currently available in the U.S., European Union, China, and South Korea. Viveve continues its efforts to achieve additional regulatory clearances in markets around the world.

About Viveve

Viveve Medical, Inc. is a medical technology company focused on women's intimate health. Viveve is committed to advancing new solutions to improve women's overall well-being and quality of life. The internationally patented Viveve® System incorporates CMRF technology to uniformly deliver volumetric heating while gently cooling surface tissue to generate neocollagenesis in a single in-office session.

Currently, in the United States, the Viveve System is cleared by the U.S. Food and Drug Administration (FDA) for use in general surgical procedures for electrocoagulation and hemostasis. International regulatory approvals and clearances have been received for vaginal laxity and/or improvement in sexual function indications in over 50 countries. Viveve is conducting VIVEVE II, a multicenter, randomized, double-blind, sham-controlled clinical trial to assess improvement of sexual function in women following vaginal childbirth. Completion of full 250 subject enrollment was announced in early March 2019. The top-line 12-month data read-out of the VIVEVE II trial is expected in April 2020. If successful, VIVEVE II results could support a marketing application for a new U.S. commercial indication.

Viveve continues to advance its clinical development program in stress urinary incontinence (SUI) and plans to initiate a short-term feasibility study upon approval by the Canadian Ministry of Health of the investigational testing application submitted in August 2019. Following the positive yet inconclusive results of the LIBERATE-International trial, the proposed feasibility study will be a single-blind, three-arm, three-month study to compare Viveve's CMRF treatment to cryogen-only treatment and to inert sham treatment in order to capture short-term safety and effectiveness data on use of the Viveve System for the improvement of SUI in women. Results of the planned three-month feasibility study are targeted for read-out in April 2020. If positive, the results could be used to support Viveve's re-submission of its Investigational Device Exemption to the FDA for approval to conduct the LIBERATE-U.S. trial designed to evaluate the safety and effectiveness of the Viveve System for improvement of SUI in women. The results of these trials, if successful, could support marketing applications in the U.S. and over 30 countries around the world for this new commercial indication.

For more information visit Viveve's website at www.viveve.com.

Safe Harbor Statement

All statements in this press release that are not based on historical fact are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. While management has based any forward-looking statements included in this press release on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of our control, which could cause actual results to materially differ from such statements. Such risks, uncertainties and other factors include, but are not limited to, the fluctuation of global economic conditions, the performance of management and our employees, our ability to obtain financing or pursue strategic alternatives, our ability to obtain approval or clearance for sale of our medical device for all indications sought, competition, general economic conditions and other factors that are detailed in our periodic and current reports available for review at www.sec.gov. Furthermore, we operate in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. We disclaim any intention to, and undertake no obligation to, update or revise forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware, unless required by law.

Investor Relations contacts:
Amato and Partners, LLC
Investor Relations Counsel
admin@amatoandpartners.com

Media contact:
Jenna Urban
Berry & Company Public Relations
(212) 253-8881
jurban@berrypr.com

SOURCE: Viveve Medical, Inc.

ReleaseID: 569570

This News Release is Intended for Distribution in Canada Only.

Not for Distribution to U.S. Newswire Services or for Release, Publication, Distribution or Dissemination Directly, or Indirectly, in Whole or in Part, in or Into the United States.

TORONTO, ON / ACCESSWIRE / December 10, 2019 / EQ Inc. (TSXV:EQ) ("EQ Works" or the "Company"), a leader in delivering location behavioural data and intelligence, is pleased to announce that it has completed a non-brokered private placement (the "Private Placement") of 6,101,830 units (the "Units") at a price of $0.75 per Unit for aggregate gross proceeds of $4,576,373.

This financing supports EQ's recently announced engagement with one of Canada's largest corporations which combines some of the richest data sets in Canada with EQ's data focused proprietary platform to provide marketers and advertisers with best-in-class and unique targeting and measurement tools.

"We are continuing to gain traction with advertisers and marketers as they look for the best ways to target, derive insights and develop AI models incorporating location behaviour data." said Geoffrey Rotstein, President and CEO of EQ Works. "This funding will enable us to continue building our data platform, develop our data science practice and further expand into the U.S."

Each Unit is comprised of one common share in the capital of the Company ("Common Share") and one-half of one common share purchase warrant (each full warrant, a "Warrant"). Each Warrant is exercisable at a price of $1.00 per Common Share, for a period of 24 months following the closing of the Private Placement. The expiry date of the Warrants may be accelerated by the Company at any time if the closing price of the Common Shares on the facilities of the TSX Venture Exchange (the "TSX-V") is greater than $1.25 for any 10 consecutive trading days following the date that is four months and one day after the closing of the Private Placement.

In connection with the Private Placement, the Company paid finders fees of $1,256 in cash and issued 1,675 finder warrants on the same terms as the Warrants.

The Company intends to use the proceeds from the Private Placement for technology development, expansion and general working capital purposes.

Pursuant to applicable securities laws, the securities issued under the Private Placement are subject to a hold period for four months and one day from the closing of the Private Placement, expiring April 11, 2020. The Private Placement remains subject to the final acceptance of the TSX-V.

About EQ Works

EQ Works (www.eqworks.com) provides a smarter way to target customers. Using first-party, location-based behaviour signals, advanced data analytics, and proprietary software, EQ Works creates and targets customized, performance-boosting audience segments. Proprietary algorithms and data generate attribution models that connect consumer behavior in the physical world to consumer behavior in the digital world, solving complex challenges for brands and agencies.

Neither the TSX-V nor its Regulation Services Provider (as that term is defined in policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking statements, which may include, without limitation, statements with respect to the use of proceeds from the Private Placement, the Company's ability to provide marketers and advertisers with targeting and measurement tools, the Company's ability to continue building its data platform and to develop data science practices and the Company's expansion into the United States. The forward-looking statements are based on management's current expectations and/or assumptions, and are subject to known and unknown uncertainties and risks, which could cause actual results to differ materially from those contemplated or implied by such forward-looking statements. When used in this press release, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among other things, the demand for EQ Works' products and services; a history of net losses; restructuring; intellectual property actions; credit risk from trade credit; changing nature of internet and mobile advertising; failure of real-time advertising exchanges to attract publishers; government regulation of the internet; system failures; competition from new customers and products; rapid technological change; lengthy sales cycles hindering adoption of EQ Works' solutions; third-party claims related to content in advertising delivered by EQ Works; as well as those factors disclosed in the Company's publicly filed documents. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements. These and other factors should be considered carefully and readers should not place undue reliance on the Company's forward-looking statements. The Company undertakes no obligation to update any forward-looking statements (unless required by law) contained herein should material facts change due to new information, future events or otherwise.

EQ Inc.
1235 Bay Street, Suite 401| Toronto, Ontario |M5R 3K4
p: 416.597.8889
press@eqworks.com
www.eqworks.com
Contact: Peter Kanniah, Chief Financial Officer

SOURCE: EQ Inc.

ReleaseID: 569709

NEW YORK, NY / ACCESSWIRE / December 10, 2019 / Wall Street Law Firm Maalouf Ashford & Talbot, LLP, one of the world's leading international law firms, has been named Law Firm of the Year for 2019 in the following countries and categories:

In the United States
▪ International Trade & Finance Law Firm of the Year
▪ Arbitration & Litigation Law Firm of the Year
▪ Corporate Law Firm of the Year
▪ M&A Law Firm of the Year
▪ Antitrust Law Firm of the Year
▪ Capital Markets Law Firm of the Year
▪ Banking & Finance Law Firm of the Year
▪ Securities Law Firm of the Year
▪ Oil & Gas Law Firm of the Year
▪ Energy Law Firm of the Year
▪ Regulatory & Compliance Law Firm
▪ Venture Capital Law Firm of the Year
▪ Project Finance Law Firm of the Year
▪ Real Estate Law Firm of the Year
▪ Private Equity Law Firm of the Year
▪ Asset Management Law Firm of the Year
▪ Tax Law Firm of the Year
▪ Intellectual Property Law Firm of the Year
▪ Islamic Finance Law Firm of the Year
▪ Shipping & Maritime Law Firm of the Year
▪ Cross Border Law Firm of the Year
▪ Renewable Energy Law Firm of the Year
▪ Mining Law Firm of the Year
▪ Full Service Law Firm of the Year

In Dubai
▪ Arbitration & Litigation Law Firm of the Year
▪ Banking & Finance Law Firm of the Year
▪ Compliance Law Firm of the Year
▪ International Finance Law Firm of the Year
▪ Intellectual Property Law Firm of the Year
▪ Media & Telecommunications Law Firm of the Year
▪ M&A Law Firm of the Year
▪ Oil & Gas Law Firm of the Year
▪ Pharmaceuticals and Biotechnology Law Firm of the Year
▪ Real Estate Law Firm of the Year
▪ Corporate Law Firm of the Year
▪ Shipping & Maritime Law Firm of the Year

In the Kingdom of Saudi Arabia
▪ Arbitration & Litigation Law Firm of the Year
▪ Corporate Law Firm of the Year
▪ Compliance Law Firm of the Year
▪ Intellectual Property Law Firm of the Year
▪ Oil & Gas Law Firm of the Year
▪ M&A Law Firm of the Year
▪ Technology, Media & Telecommunications Law Firm of the Year

In Egypt
▪ Arbitration & Litigation Law Firm of the Year
▪ Corporate Law Firm of the Year
▪ Compliance Law Firm of the Year
▪ Pharmaceuticals and Biotechnology Law Firm of the Year
▪ Technology, Media & Telecommunications Law Firm of the Year
▪ Intellectual Property Law Firm of the Year

In Bahrain
▪ Arbitration & Litigation Law Firm of the Year
▪ Banking & Finance Law Firm of the Year
▪ Corporate Law Firm of the Year
▪ Oil & Gas Law Firm of the Year

In Qatar
▪ Arbitration & Litigation Law Firm of the Year
▪ International Finance Law Firm of the Year
▪ Corporate Law Firm of the Year
▪ Technology, Media & Telecommunications Law Firm of the Year
▪ Intellectual Property Law Firm of the Year
▪ M&A Law Firm of the Year

In Lebanon
▪ Arbitration & Litigation Law Firm of the Year
▪ Banking & Finance Law Firm of the Year
▪ Corporate Law Firm of the Year
▪ Oil & Gas Law Firm of the Year

In Iraq
▪ Arbitration & Litigation Law Firm of the Year
▪ International Finance Law Firm of the Year
▪ Corporate Law Firm of the Year
▪ Pharmaceuticals and Biotechnology Law Firm of the Year
▪ Regulatory Law Firm of the Year
▪ Compliance Law Firm of the Year

In Jordan
▪ Arbitration & Litigation Law Firm of the Year
▪ International Finance Law Firm of the Year
▪ Corporate Law Firm of the Year
▪ Pharmaceuticals and Biotechnology Law Firm of the Year
▪ Regulatory Law Firm of the Year
▪ Compliance Law Firm of the Year

In Morocco
▪ Arbitration & Litigation Law Firm of the Year
▪ International Finance Law Firm of the Year
▪ Corporate Law Firm of the Year
▪ Pharmaceuticals and Biotechnology Law Firm of the Year
▪ Regulatory Law Firm of the Year
▪ Compliance Law Firm of the Year

In the United Kingdom
▪ International Finance Law Firm of the Year
▪ M&A Law Firm of the Year

In China
▪ Corporate Law Firm of the Year
▪ M&A Law Firm of the Year
▪ Banking & Finance Law Firm of the Year
▪ Oil & Gas Law Firm of the Year

In Brazil
▪ M&A Law Firm of the Year
▪ Corporate Law Firm of the Year
▪ Oil & Gas Law Firm of the Year

Below please find a link to the awards:
http://www.maaloufashford.com/uploads/1/3/2/7/13275915/inter-continential_finance_law_awards_-_2019.pdf

With offices in financial centers around the globe, including: New York City, Dubai, Riyadh, Jeddah, Dammam, Beirut, Cairo, Baghdad, Erbil, Amman, Zürich, Casablanca, Hong Kong, Shanghai and São Paulo, and affiliated offices in over 80 other countries, Maalouf Ashford & Talbot remains at the forefront of the legal profession in structuring complex international business transactions and representing clients in high-profile matters involving corporate law, mergers and acquisitions, international arbitration, IPO's, banking law, real estate law, international oil & gas transactions, private equity, environmental law, pharmaceuticals law, telecommunications law, intellectual property, project finance, and cross-border transactions worldwide. Maalouf Ashford & Talbot, LLP represents some of the world's most respected companies, and countries, in connection with their complex and sophisticated international business transactions.

About Dr. John J. Maalouf

Dr. John J. Maalouf, Senior Partner of the Firm, is one of Wall Street's top lawyers and is a globally recognized expert in the areas of International Trade & Finance Law, International Arbitration, Corporate & Business Law, Banking Law, Mergers & Acquisitions, Oil & Gas Law, Pharmaceuticals Law, Telecommunications Law, and Intellectual Property Law.

In addition to being one of the world's leading lawyers, Dr. Maalouf is also an International Arbitrator with the following Courts of International Arbitration and International Arbitration Centers:

London Court of International Arbitration (LCIA)
Dubai International Financial Center/LCIA (DIFC/LCIA)
Dubai International Arbitration Centre (DIAC)
Swiss Arbitration Association (ASA)
Emirates Maritime Arbitration Centre (EMAC)
International Council for Commercial Arbitration (ICCA – The Hague, The Netherlands)
Financial Industry Regulatory Authority (FINRA – United States of America)
Australian Centre for International Commercial Arbitration (ACICA)
British Columbia International Commercial Arbitration Centre (BCICAC) and
GCC Arbitration Centre (Bahrain)

As an International Arbitrator, Dr. Maalouf has over 12 years of experience deciding large international commercial disputes between multinational companies around the world.

Dr. Maalouf's accomplishments and abilities are well known among Fortune 500 and Global 500 companies, and have led to him being interviewed on CNN and Al Arabiya, below are the links to those interviews:

https://www.youtube.com/watch?time_continue=2&v=XGeslJVjeQg

https://www.youtube.com/watch?v=mtwz4UqFVkQ

Dr. Maalouf is also a member of MENSA, the International High IQ Society, and was featured in the following MENSA International Journal Article:

http://www.maaloufashford.com/uploads/1/3/2/7/13275915/mensa_international_journal__john_j._maalouf

Additionally, below is a link to the U.S. News and World Report information on Dr. Maalouf:

https://lawyers.usnews.com/lawyers/john-joseph-maalouf/329808

Contact Information: Lisa Stone, New York City Office Manager: lisa.stone@maaloufashford.com

SOURCE: Maalouf Ashford & Talbot, LLP

ReleaseID: 569553

NIAGARA FALLS, ON / ACCESSWIRE / December 10, 2019 / EnerDynamic Hybrid Technologies Corp. (TSXV:EHT) ("EHT") is pleased to report that it has achieved a major breakthrough in its solar panel construction and output.

EHT has been able to use a back contact solar back sheet and integrate its ENERTEC fiberglass material to achieve a solar module that can provide over 25 watts per sq. foot of roof space. This new module will provide a more uniform power flow and less power loss over the lifetime of the module, which will be over 50 years. The fact each cell will now work independently of each other will allow the output of the module to be more consistent and reduce power losses due to shading and other environmental factors. Additionally, the removal of the need for standard bussing currently in a typical solar module drastically increases the new modules' durability and power flow, thereby increasing power output and the resilience of the EHT solar module.

This breakthrough, which has been over a year in the works, allows EHT to power all its integrated solutions, homes, shelters, power wagons, and most importantly its micro-grow units more efficiently and thus demand less battery storage. This is a great leap forward and a welcomed addition to the EHT product line.

EHT will have the new equipment up and running at its Niagara Falls facility by the second quarter of 2020; in the meantime, EHT will utilize its relationship with the company it is purchasing the equipment from to make the panels at their facility until such time. All the projects/units that EHT is currently manufacturing, including the EHT Micro-Grow Unit in Niagara Falls that has just been completed and is ready for submission to Heath Canada for Medical Grade Cannabis Production in the next week, will have the new panel technology built into them.

John Gamble, CEO of EHT and fresh off a successful European trip to finalize this technological enhancement breakthrough, commented, "This is a major milestone in EHT; this achievement puts us back at the forefront in the solar industry with not only a lightweight panel but one that can outperform all of the other modules in the industry."

About EnerDynamic Hybrid Technologies

EHT delivers proprietary, turn-key energy solutions which are intelligent, bankable and sustainable. EHT's expertise includes the development of its ENERTEC module structures with full integration of smart energy solutions. Using a proprietary skin and foam core that is stronger than traditional wood or steel structural insulated panels, EHT provides exceptional thermal energy efficiency in modular homes, cold storage facilities, residential/commercial out buildings and emergency/temporary shelters. EHT works with its partners worldwide to erect the buildings on-site utilizing EHT staff and local crews. In addition to traditional support to established electrical networks, ENERTEC buildings excel where no electrical grid exists.

About ENERTEC

The EHT advanced ENERTEC Modular Wall and Roof System uses a proprietary skin and foam core that is stronger and more energy efficient than traditional wood or steel structures providing the highest ratings for energy efficiency. EHT works with its partners worldwide to erect the buildings on-site utilizing EHT staff and local crews. After installation, each structure can be furnished and finished to meet the customer's requirements including siding, tile, kitchens and bathrooms or segregated commercial rooms. The finished wall product can be shipped on pallets and delivered via rail, truck or water in standard formats.

At the core of the ENERTEC product line is the ENERTEC Embedded Solar Roof Module. Solar cells can be embedded in a proprietary fire proof skin resulting in substantial cost savings by eliminating heavy glass panels and aluminum racking required for traditional solar panels. Two barriers to greater adoption of solar energy are weight limitations of the roof on which solar panels could be deployed and onerous shipping and labour costs. A lighter product at a better price point will open a larger market for solar due to the faster return of capital investment especially for rural and remote users looking to go off-grid. Furthermore, the entire EHT embedded solar roof becomes a massive solar panel capable of producing significantly more energy than the home requires, allowing the structure to then become an important source of power for the local micro grid or large battery storage systems.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The statements herein that are not historical facts are forward‐looking statements. Forward-looking information relating to sales of the products (the "Opportunities") involves risk, uncertainties and other factors that could cause actual events, results, performance, prospects, for the Opportunities to differ materially from those expressed or implied by such forward-looking information. Although EHT believes that the assumptions used in preparing the forward-looking information on the Opportunities outlined in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. EHT disclaims any intention or obligation to update or revise any forward-looking information, whether a result of new information, future events or otherwise, other than as required by applicable securities laws.

FOR FURTHER INFORMATION PLEASE CONTACT

John Gamble
CEO, Director
(289) 488-1699
jgamble@ehthybrid.com
info@ehthybrid.com
Website: www.ehthybrid.com

SOURCE: EnerDynamic Hybrid Technologies Corp.

ReleaseID: 569732

VANCOUVER, BC / ACCESSWIRE / December 10, 2019 / Klondike Gold Corp. (TSXV:KG)(FRA:LBDP)(OTC:KDKGF) ("Klondike Gold" or the "Company") is pleased to provide an update to the working exploration model which identifies newly recognized northeast trending orogenic faults and links these faults to gold mineralization. The updated exploration model is a result of a comprehensive three-month reprocessing and recompilation program of collected data involving in-house personnel and structural, geophysical, and LiDAR outside consultants. This new exploration model more adequately explains the recent gold discovery in drill hole EC19-267 which intersected mineralization grading 1,009 g/t Au with 1,035 g/t Ag over 1.0 meter (104.00-105.00 m) and provides vectors towards new exploration targets at the Lone Star and Stander zones. These areas, among others, will continue to be the focus of drilling and exploration efforts in 2020.

EXPLORATION MODEL OVERVIEW

The new orogenic structural model identifies three phases of early deformation ("D1" to "D3") associated with obduction of the Klondike island arc terrain onto continental North America, which created northwest-southeast oriented unmineralized faults through the Klondike District. A later post-obduction deformation phase ("D4"), recognized in outcrops in 2018 and recently documented in outcrop, oriented-drill core, in multiple geophysics and LiDAR datasets, and also in the topography (see Figure 1) shows approximately northeast-southwest oriented faults which dip northwesterly. This represents an almost 90-degree rotation of the main compressional stress direction, and is implied to occur well after (D1 to D3) terrain obduction.

The exploration model essentially recognizes that northeast-trending "D4" faults are responsible for gold mineralization, and that the D4 fault process also reactivated and introduced gold mineralization into some earlier "D3" northwest-trending faults. Historically the D3 faults have been the focus of all exploration in the Klondike District to date and were previously considered to be the only faults with gold mineralization.

The Lone Star Zone and Stander Zone are both (D3-related) structures cross-cut by the newly recognized (D4) faulting. The Company interprets the recent Stander Zone gold intersection in drill hole EC19-267 of mineralization grading 1,009 g/t Au with 1,035 g/t Ag over 1.0 meter (104.00-105.00 m) to be situated at the intersection of localized northwesterly (D3) and northeasterly (D4) trending structures.

Also recognized are subsequent post-mineralization north-northwest ("D5") faults containing Cretaceous age mafic, felsic and lamprophyre dykes which indicate a direct magmatic connection to the upper mantle. Most recent intrusions of north-south trending, reverse-magnetic-polarity ("D6") Eocene porphyry dykes complete the structural evolution.

FIGURE 1: STRUCTURAL MODEL SHOWCASING D3 AND D4 FAULTS ON LONE STAR RIDGE

Figure 1 provides an illustrative sketch of a potentially gold mineralized fault network. The new D4 (yellow) northeast trending faults are readily identifiable as gulches which connect between the two major thrust faults (purple) which occupy the major creeks and parallel secondary D3 reactivated faults (red).

The Company has mapped four D3 faults reactivated during the D4 gold mineralizing event, namely;

Bonanza Fault (hosting Lone Star Zone)
Nugget Fault (hosting Stander Zone)
Eldorado Fault (hosting the Gay Gulch showing)
Irish Fault (hosting the Violet showing)

The Company has also provisionally identified five northeast (D4) cross-faults in the same area which correspond directly to the pattern of creeks drainage (represented in yellow in Figure 1). The recognition and mapping of the D4 orogenic faults across multiple datasets and linking these faults to gold mineralization provides explanation for the distribution of gold in faults within the Klondike District. These northeast (D4) faults, the extensions of northwest D3 faults and the structural intersection of the (D3/D4) fault systems are considered primary targets of 2020 gold exploration.

GEOPHYSICAL EXPRESSION OF LONE STAR ZONE

The Lone Star Zone is known from drilling to be a broad zone hosting disseminated gold mineralization associated with the Bonanza Fault. A one-kilometer length by 200-meter width has been systematically drilled from 2016 to 2018 with relatively consistent gold grades across broad intervals. Additional drilling in 2019 tested for along-strike continuation of this mineralization with assay results pending.

The Lone Star Zone is recognized in gold-bearing outcrops and drilling for approximately 3 kilometers. The Lone Star Zone is directly correlated with gold-in-soils, very-low-frequency ("VLF") electromagnetics, reduced-to-pole magnetics and total field magnetics for an additional 4.5 kilometers with little exploration to date along this length, for a total interpreted length of approximately 7.5 kilometers.

GEOPHYSICAL EXPRESSION OF STANDER ZONE

The "Stander Zone" is the new name (previously ‘Nugget' and others) for the zone of quartz veining containing coarse gold mineralization found in outcrop on the east side of Eldorado Creek. The name remembers Anton Stander who was the first discoverer of placer gold in Eldorado Creek in August 1896.

The Stander Zone is recognized in gold-bearing outcrops and drilling for approximately 4 kilometers. The Stander Zone is recognizable in coincident tilt-derivative magnetics plus gold-in-soil anomalies for an additional 8 kilometers with no exploration to date along this length, for a total interpreted length of 12 kilometers.

The Stander Zone has been tested in various localized areas along approximately a 2-kilometer extent. Additional drilling in 2019 tested the area adjacent to the 1,009 g/t Au with 1,035 g/t Ag over 1.0 meter intersection with assay results pending.

2019 ASSAYS PENDING

Remaining unreleased 2019 drill results are undergoing interpretation and review in light of the new structural information and exploration model updates and will be forthcoming upon completion of this review. Results from other work such as additional soil sampling, GT-Probe surveying, rock sampling and oriented core analysis are also pending.

OTHER ACTIVITIES

Klondike Gold recently attended the 46th Annual Yukon Geoscience Forum and Trade Show organized by the Yukon Chamber of Mines and separately the 2019 Yukon Placer Forum organized by the Yukon Geological Survey. Peter Tallman, CEO, gave a technical presentation at the Geoscience Forum entitled "Structural Evolution and Timing of Gold Mineralization in the Klondike District, Yukon" and a second technical presentation at the Placer Forum entitled "Bedrock Gold Discoveries Explain Nearby Placer Deposits: A Model for Finding Placer Gold". These presentations incorporate concepts and information described in this news release.

QUALIFIED PERSONS REVIEW

The technical and scientific information contained within this news release has been reviewed and approved by Ian Perry, P.Geo., Vice-President Exploration of Klondike Gold Corp. and Qualified Person as defined by National Instrument 43-101 policy.

ABOUT KLONDIKE GOLD CORP.

Klondike Gold Corp. is a Canadian exploration company with offices in Vancouver, British Columbia, and Dawson City, Yukon Territory. The Company is focused on exploration and development of the Lone Star gold target at the confluence of Bonanza and Eldorado Creeks, within a district scale 576 square kilometer property accessible by government-maintained roads located on the outskirts of Dawson City, YT within the Tr'ondëk Hwëch'in First Nation traditional territory.

On behalf of KLONDIKE GOLD CORP.

"Peter Tallman"

President and CEO
(604) 609-6138
E-mail: info@klondikegoldcorp.com
Website: www.klondikegoldcorp.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Disclaimer for Forward-Looking Information

"This press release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities laws. This information and statements address future activities, events, plans, developments and projections. All statements, other than statements of historical fact, constitute forward-looking statements or forward-looking information. Such forward-looking information and statements are frequently identified by words such as "may," "will," "should," "anticipate," "plan," "expect," "believe," "estimate," "intend" and similar terminology, and reflect assumptions, estimates, opinions and analysis made by management of Klondike in light of its experience, current conditions, expectations of future developments and other factors which it believes to be reasonable and relevant. Forward-looking information and statements involve known and unknown risks and uncertainties that may cause Klondike's actual results, performance and achievements to differ materially from those expressed or implied by the forward-looking information and statements and accordingly, undue reliance should not be placed thereon.

Risks and uncertainties that may cause actual results to vary include but are not limited to the availability of financing; fluctuations in commodity prices; changes to and compliance with applicable laws and regulations, including environmental laws and obtaining requisite permits; political, economic and other risks; as well as other risks and uncertainties which are more fully described in our annual and quarterly Management's Discussion and Analysis and in other filings made by us with Canadian securities regulatory authorities and available at www.sedar.com. Klondike disclaims any obligation to update or revise any forward-looking information or statements except as may be required."

SOURCE: Klondike Gold Corp.

ReleaseID: 569660